Cancer cells not only lose polarized (luminal) expression of CEA, but actively cleave CEA from their surface by phospholipases, an action that results in serum concentrations of CEA that can approach 5 μg/mL [3], [4], [5]. This evidence concerns the gene CEACAM3 and cancer.